It’s one of the most common questions we hear during Semaglutide consultations at Perpetual Health Group — and it’s a fair one to ask before starting any GLP-1 medication.

Semaglutide carries a warning related to a specific, rare type of thyroid cancer (medullary thyroid carcinoma) seen in some animal studies. This doesn’t mean everyone with a thyroid condition is automatically excluded — most patients with well-managed hypothyroidism or hyperthyroidism from unrelated causes tolerate Semaglutide without issue. What matters is your specific thyroid history, and that’s exactly why we don’t prescribe based on a form you fill out online.

During your consultation, we review your full thyroid history, current labs, and any family history of thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) before recommending Semaglutide, Tirzepatide, or an alternative path like our natural Blueprint Weight Loss Program.

If you’re managing a thyroid condition and curious whether medical weight loss is right for you, a consultation is the way to find out — not guesswork.

This post is for general education and isn’t a substitute for medical advice. Talk to your provider about your specific health history.